Clinical trial · Observational
Symptomatic and Incidental RCC Detection
Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities
NCT07004426CI-TRIAL-00105964KIDCaDcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Renal Neoplasm | Benign Kidney Neoplasm | ALIAS | 0.90 |
| Renal Carcinoma | Kidney Carcinoma | ALIAS | 0.90 |
| Renal Cell Carcinoma (Kidney Cancer) | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgical treatment of renal lesions | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- A single patient group undergoing intervention for renal lesions
- interventionNames
- Procedure: Surgical treatment of renal lesions
Primary outcomes (1)
- measure
- Detection-specific renal cell carcinoma (RCC) proportions
- timeFrame
- From 2011 to 2020
- description
- Detection-specific renal cell carcinoma (RCC) proportions, defined as the proportion of each detection type relative to all RCC cases. Results will be stratified by stage, histological type, and imaging modality.
Secondary outcomes (1)
- measure
- Proportion of RCC among neoplastic and non-neoplastic renal lesions
- timeFrame
- From 2011 to 2020
- description
- Proportion of RCC among neoplastic and non-neoplastic renal lesions, stratified by investigated covariates (e.g., age, sex, smoking status, BMI, or hypertension treatment).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * patients over 18 years of age undergoing surgical treatment for renal lesions Exclusion Criteria: * patients undergoing surgery for non-renal and urotelial carcinoma, including unknown * patients with recurrent renal lesions
References
Publications (0)
Data not yet available
No reference posted for this study.